首站-论文投稿智能助手
典型文献
Differential gene screening and functional analysis in docetaxel-resistant prostate cancer cell lines
文献摘要:
Objective Docetaxel-based combination chemotherapy has traditionally been the standard treatment for metastatic castration-resistant prostate cancer (PCa). However, most patients eventually develop resistance to this treatment, which further reduces their survival. This study aimed to determine key molecular genes in docetaxel-resistant PCa cell lines using bioinformatic approaches.Methods The analysis of microarray data GSE33455 (including DU-145/DU-145R and PC-3/PC-3R cell lines) obtained from the Gene Expression Omnibus (GEO) database was performed using GEO2R. Differentially expressed genes (DEGs) of DU-145/DU-145R and PC-3/PC-3R cell lines were selected, and the intersection of DEGs between the two groups was obtained. DEGs were annotated with the Gene Ontology (GO) function and enriched with the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway using an online platform (). The online tool Search Tool for the Retrieval of Interacting Genes () was used to obtain the DEG network graph and matrix list, which was imported into Cytoscape 3.6.1 and analyzed using the Molecular Complex Detection plug-in to detect potential functional modules in the network. Results A total of 131 intersection DEGs were identified between non-treated and docetaxel-resistant PCa cell lines. GO functional annotation showed that the main genes involved were present in the plasma membrane and were involved in positive regulation of ubiquitin-protein transferase activity, positive regulation of pseudopodium assembly, centriolar subdistal appendage, and heterophilic cell–cell adhesion via plasma membrane cell adhesion molecules. KEGG pathway enrichment analysis revealed that DEGs were mainly involved in IL-17 signaling pathway, cytokine-cytokine receptor interaction, rheumatoid arthritis, legionellosis, and folate biosynthesis. We identified two distinct hubs of DEGs: (1) CD274, C-X-C motif chemokine ligand (CXCL)1, DExD/H-box helicase 58, CXCL2, CXCL8, colony-stimulating factor 2, C-X-C motif chemokine receptor 4 (CXCR4), CXCL5, and CXCL6 and (2) argininosuccinate lyase, argininosuccinate synthase 1, and asparagine synthetase. Except for the CXCR4 gene that was downregulated, the other 11 genes showed upregulated expression. Conclusion Certain differential genes may be potential targets for predicting and treating metastatic docetaxel-resistant Pca.
文献关键词:
作者姓名:
Ming Wang;Lei Wang;Yan Zhang;Chaoqi Wang;Shuang Li;Tao Fan
作者机构:
Department of Urinary Surgery,Affiliated Hospital of Inner Mongolia University for the Nationalities,Tongliao 028007,China;Department of Pathology,The People's Hospital of China Three Gorges University,The First People's Hospital of Yichang,Yichang 443000,China;Department of Oncology&Hematology,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Wuhan 430015,China
引用格式:
[1]Ming Wang;Lei Wang;Yan Zhang;Chaoqi Wang;Shuang Li;Tao Fan-.Differential gene screening and functional analysis in docetaxel-resistant prostate cancer cell lines)[J].肿瘤学与转化医学(英文),2022(02):94-99
A类:
GSE33455,145R,pseudopodium,centriolar,subdistal,heterophilic,legionellosis,DExD
B类:
screening,functional,analysis,docetaxel,resistant,prostate,cancer,cell,lines,Objective,Docetaxel,combination,chemotherapy,traditionally,been,standard,treatment,metastatic,castration,PCa,However,most,patients,eventually,develop,resistance,this,which,further,reduces,their,survival,This,study,aimed,determine,key,molecular,genes,using,bioinformatic,approaches,Methods,microarray,including,DU,3R,obtained,from,Expression,Omnibus,database,was,performed,GEO2R,Differentially,expressed,DEGs,were,selected,intersection,between,groups,annotated,Ontology,enriched,Kyoto,Encyclopedia,Genes,Genomes,pathway,online,platform,tool,Search,Tool,Retrieval,Interacting,used,network,graph,matrix,list,imported,into,Cytoscape,analyzed,Molecular,Complex,Detection,plug,detect,potential,modules,Results,total,identified,treated,annotation,showed,that,involved,present,plasma,membrane,positive,regulation,ubiquitin,protein,transferase,activity,assembly,appendage,adhesion,via,molecules,enrichment,revealed,mainly,signaling,cytokine,receptor,interaction,rheumatoid,arthritis,folate,biosynthesis,We,distinct,hubs,CD274,motif,chemokine,ligand,box,helicase,CXCL2,CXCL8,colony,stimulating,CXCR4,CXCL5,CXCL6,argininosuccinate,lyase,synthase,asparagine,synthetase,Except,downregulated,upregulated,expression,Conclusion,Certain,differential,may,targets,predicting,treating,Pca
AB值:
0.546064
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Qiong Wang;Zean Li;Jin Yang;Shirong Peng;Qianghua Zhou;Kai Yao;Wenli Cai;Zhongqiu Xie;Fujun Qin;Hui Li;Xu Chen;Kaiwen Li;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Pathology,School of Medicine,University of Virginia,Charlottesville,VA 22908,USA;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Radiation Oncology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Department of Radiology,Massachusetts General Hospital,Harvard Medical School,Boston,MA 02114,USA;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
Jin-ping Pang;Chao Shen;Wen-fang Zhou;Yun-xia Wang;Lu-hu Shan;Xin Chai;Ying Shao;Xue-ping Hu;Feng Zhu;Dan-yan Zhu;Li Xiao;Lei Xu;Xiao-hong Xu;Dan Li;Ting-jun Hou-Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences,Cancer Hospital of University of Chinese Academy of Sciences,Zhejiang Cancer Hospital,Hangzhou 310022,China;School of Life Science,Huzhou University,Huzhou 313000,China;Institute of Bioinformatics and Medical Engineering,School of Electrical and Information Engineering,Jiangsu University of Technology,Changzhou 213001,China;State Key Lab of CAD&CG,Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。